New medicament for treating leukemia

Abstract

The invention provides a new medicament for treating leukemia, which is prepared from 39 raw material drugs, such as taxus chinensis (tree bark), tender catchweed bedstraw herb, prismatomeria tetrandra, isatis indigotica fort, tuber fleeceflower stem, Yunnan fringed iris herb, fructus corni, hemlock parsley, turtle shell and the like, wherein the taxus chinensis (tree bark) contains 'taxol' which is the top anti-cancer medicament in the world, can be combined with trace of albumin, so that the albumin is accelerated to be aggregated, mitosis of cancer cells can be inhibited, and proliferation of the cancer cells can be effectively stopped. The medicament also comprises the tender catchweed bedstraw herb, suncured ginseng, prismatomeria tetrandra, isatis indigotica fort, tuber fleeceflower stem, Yunnan fringed iris herb, fructus corni, hemlock parsley and turtle shell, so that growth and development of the cancer cells can be controlled, the cancer resistance of a human body can be reinforced, the circulation and metabolic function of the human body can be improved, virus accumulated in the human body is removed outside the body through urine and defecation to achieve the function of preventing cancer. The medicament adopts the Chinese medicaments capable of nourishing yin and supplementing kidney, supplying vital energy, nourishing and activating blood, tonifying qi and controlling blood, softening hardness to dissipate stagnation, removing toxicity and tonifying middle-Jiao and coordinating drug actions of a prescription, administration is increased or reduced according to the course development and classification of the leukemia to achieve the best treatment effect. 38 leukemia cases are treated non-selectively in clinical application, and the total effective rate is over 90 percent.

Description

technical field [0001] The invention relates to a new drug for treating blood cancer, which belongs to the technical field of traditional Chinese medicine. Background technique [0002] Blood cancer, collectively referred to as leukemia in medicine, is an incurable disease that threatens people's lives. At present, the treatment methods used in medicine are blood transfusion, radiotherapy, chemotherapy or bone marrow transplantation. These treatment methods have serious side effects, long treatment period, and high cost (bone marrow transplantation is at least 400,000 yuan or more, and it is not easy to match), which is difficult for ordinary patients to afford, and the effect is not ideal; traditional Chinese medicine has a long history of treating blood cancer. Historically, it is recorded in medical works such as "Compendium of Materia Medica", "Materia Medica Seeking Truth", "Encyclopedia of Ulcer Medicine" and other medical works. It is believed that the occurrence of...

AI Technical Summary

Problems solved by technology

These treatment methods have serious side effects, long treatment period, and high cost (bone marrow transplantation is at least 400,000 yuan or more, and it is not easy to match), which is difficult for ordinary patients to afford, and the effect is not ideal; traditional Chinese medicine has a long history of treating blood cancer. Historically, it is recorded in medical works such as "Compendium of Materia Medica", "Materia Medica Seeking Truth", "Encyclopedia of Ulcer Medicine" and other medical works. It is believed that the occurrence of cancer is caused by the imbalance between human oncogenes and tumor suppressor genes, and the root cause of the imbalance lies in the immune system Regulating the immune system, combined with the anti-cancer ingredients contained in traditional Chinese medicine, can fundamentally treat cancer; therefore, the majority of patients hope to have a low-cost, quick-acting, and effective traditional Chinese medicine for treating blood cancer, so as to alleviate the physical pain of patients. Pain, reduce treatment costs, promote social progress